Endothelial, pericyte and tumor cell expression in glioblastoma identifies fibroblast activation protein (FAP) as an excellent target for immunotherapy-Reference-Cited by-同舟云学术

Endothelial, pericyte and tumor cell expression in glioblastoma identifies fibroblast activation protein (FAP) as an excellent target for immunotherapy

Published:2020-01 Issue:10 Volume:9 Page:
ISSN:2050-0068
Container-title:Clinical & Translational Immunology
language:en
Short-container-title:Clin. Transl. Immunol.

Author:

Ebert Lisa M¹²^ORCID,Yu Wenbo¹,Gargett Tessa¹²,Toubia John¹,Kollis Paris M¹²,Tea Melinda N¹,Ebert Brenton W¹,Bardy Cedric³⁴,van den Hurk Mark³⁴,Bonder Claudine S¹²,Manavis Jim²,Ensbey Kathleen S⁵,Oksdath Mansilla Mariana¹,Scheer Kaitlin G¹⁶,Perrin Sally L¹⁶,Ormsby Rebecca J⁴,Poonnoose Santosh⁴⁷,Koszyca Barbara⁸,Pitson Stuart M¹²,Day Bryan W⁵⁹¹⁰,Gomez Guillermo A¹,Brown Michael P¹²¹¹

Affiliation:

1. Centre for Cancer Biology SA Pathology and University of South Australia Adelaide Australia

2. Adelaide Medical School University of Adelaide Adelaide Australia

3. South Australian Health and Medical Research Institute (SAHMRI) Adelaide Australia

4. College of Medicine & Public Health Flinders University Adelaide Australia

5. Department of Cell and Molecular Biology Sid Faithfull Brain Cancer Laboratory QIMR Berghofer Medical Research Institute Brisbane QLDAustralia

6. Clinical and Health Sciences University of South Australia Adelaide Australia

7. Department of Neurosurgery Flinders Medical Centre Bedford Park Australia

8. Department of Anatomical Pathology SA Pathology Adelaide Australia

9. Faculty of Health Queensland University of Technology Brisbane QLD Australia

10. Faculty of Medicine The University of Queensland Brisbane QLD Australia

11. Cancer Clinical Trials Unit Royal Adelaide Hospital Adelaide Australia

Funder

Cancer Council South Australia

Centre of Excellence in Cognition and its Disorders, Australian Research Council

Neurosurgical Research Foundation

Cure Brain Cancer Foundation

National Health and Medical Research Council

Children's Brain Tumor Foundation

Flinders Medical Centre Foundation

Aard- en Levenswetenschappen, Nederlandse Organisatie voor Wetenschappelijk Onderzoek

Publisher

Wiley

Subject

General Nursing,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cti2.1191

Reference78 articles.

1. Clinical chimeric antigen receptor‐T cell therapy: a new and promising treatment modality for glioblastoma

2. Trivalent CAR T‐cells overcome interpatient antigenic variability in glioblastoma;Bielamowicz K;Neuro Oncol,2017

3. EphA3 pay‐loaded antibody therapeutics for the treatment of glioblastoma;Offenhauser C;Cancers (Basel),2018

4. CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicity

5. EGFR806-CAR T cells selectively target a tumor-restricted EGFR epitope in glioblastoma

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer associated fibroblasts and metabolic reprogramming: unraveling the intricate crosstalk in tumor evolution;Journal of Hematology & Oncology;2024-09-02

2. CAR-based therapeutic targets in pediatric high-grade glioma;2024-08-28

3. Fibroblast activation protein constitutes a novel target of chimeric antigen receptor T‐cell therapy in solid tumors;Cancer Science;2024-08-21

4. CAFs and T cells interplay: The emergence of a new arena in cancer combat;Biomedicine & Pharmacotherapy;2024-08

5. CAR-T cell technologies that interact with the tumour microenvironment in solid tumours;Expert Review of Clinical Immunology;2024-07-17